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Highlights: 
 The present study developed Nitro-Carba Test (NCT), a rapid and simple 
chromogenic method for screening of Carbapenemase-producing Enterobacteriaceae 
(CPE). 
 The NCT detected all 31 CPEs within a timeframe of only 10 seconds to 12 min. 
 The sensitivity for all three carbapenems was 100%, while specificity of IPM, MEM 
and ETP were 64.29%, 91.07% and 100%, respectively.  
 IPM, MEM and ETP against all carbapenemase-producing strains had MIC values 
ranging from 0.5 to ≥256 µg/mL, 0.25 to ≥256 µg/mL and 1 to ≥256 µg/mL, 
respectively.  
 OXA-48-producing isolates showed lower MIC values compared with producers of 
MBL and KPC. 
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Abstract 
Objectives:  The present study developed Nitro-Carba Test (NCT), a rapid and simple 
chromogenic method for screening of Carbapenemase-producing Enterobacteriaceae (CPE). 
 
Methods:  The NCT was validated with a total of 31 carbapenemase-producing isolates (9 
KPCs, 11 MBLs and 11 OXA-48s) and with 56 non-carbapenemase-producing strains. The 
assay relies on the hydrolysis of nitrocefin in the presence of carbapenems. The 
carbapenemases were extracted with lysis buffer prior to addition to wells with and without 
imipenem (IPM), meropenem (MEM) and ertapenem (ETP). Following the addition of 
nitrocefin, a change in colour from yellow to red, indicating carbapenemase production, was 
observed within 20 min. The susceptibility profiles of each bacterial strain were also 
investigated.   
 
Results: A NCT detected all 31 CPEs within a timeframe of only 10 seconds to 12 min. All 
carbapenemase producers hydrolyzed nitrocefin in all wells. No colour change in the wells 
with carbapenems was observed in non-carbapenemase producers. The sensitivity for all 
three carbapenems was 100%, while specificity of IPM, MEM and ETP were 64.29%, 
91.07% and 100%, respectively. IPM, MEM and ETP against all carbapenemase-producing 
strains had MIC values ranging from 0.5 to ≥256 µg/mL, 0.25 to ≥256 µg/mL and 1 to ≥256 
µg/mL, respectively. OXA-48-producing isolates showed lower MIC values compared with 
producers of MBL and KPC. 
 
Conclusion: This assay is a promising method detecting CPE rapidly. The NCT is a simple 
and reliable method, capable of detecting CPE in even carbapenem-susceptible strains. 
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1. Introduction 
Resistance to carbapenems, a last resort of β-lactam treating infections caused antibiotic-
resistant Enterobacteriaceae, has been increasingly documented worldwide as a consequence 
of increased consumption for the treatment of extended-spectrum-β-lactamase (ESBL)-and 
AmpC β-lactamase-producing bacteria [1-3]. Carbapenem resistance is mediated by the 
production of carbapenemase enzymes [4,5]. Overproductions of especially AmpC β-
lactamases combined with porin loss/modification have also been reported in 
Enterobacteriaceae [ 6].  
 
There are a number of carbapenemase-encoded genes which have been identified recently, 
however, the most prevalent carbapenemases in Enterobacteriaceae in the clinical setting and 
community-acquired infections are Ambler class A Klebsiella pneumoniae carbapenenases 
(KPCs), class B metallo-β-lactamases (MBLs; e.g. New Delhi metallo-β-lactamases (NDM), 
Verona integron-encoded metallo-β-lactamases (VIM) and Imipenemase (IMP)), and class D 
oxacillinase with carbapenemase activity  (e.g. OXA-48 and its variants)[7]. The emergence 
of these genotypes is different depending on geographical area. For instance, the first KPC-
producing isolate was discovered in the United States and then disseminated to Israel, 
Greece, Italy, China and other countries worldwide[8]. The NDM and OXA-48-like 
carbapenemases were originally identified in the Indian subcontinent and also Turkey, while 
Greece and Japan are endemic areas of VIM and IMP, respectively [1, 9].   
 
Treatment of carbapenemase-producing bacterial infections is very challenging due to paucity 
of optimal choice of effective antibiotics. Colistin (also known as polymyxin E), fosfomycin, 
and tigecycline are antibiotics of choice that have been often used for treating these 
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recalcitrant infections[10]. To treat these infections effectively, early detection of 
carbapenemase production is necessary.  The present study, therefore, developed a rapid and 
simple method called Nitro-Carba test (NCT) for screening of carbapenemase-producing 
Enterobacteriaceae (CPE). The method developed in our study is able to detect 
carbapenemase production within 20 min. Nitrocefin is a chromogenic substrate that is 
commonly utilized to detect the production of β-lactamase enzymes in bacteria. It has been 
previously found that meropenem prevented the hydrolysis of nitrocefin by AmpC β-
lactamase (CMY-2) [11]. In addition Ertapenem prevented nitrocefin hydrolysis by ESBL, 
AmpC and co-production of ESBL and AmpC β-lactamases [ 12].  
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2. Material and Methods 
2.1 Bacterial Isolates 
The performance of a NCT for rapid screening of carbapenemase production in 
Enterobacteriaceae was evaluated against 31 carbapenamase-producing isolates (9 KPCs, 11 
MBLs and 11 OXA-48 like) and 56 molecular confirmed non-carbapenemases (15 ESBLs, 
32 AmpCs and 9 ESBLs+AmpCs), all confirmed by molecular methods. A reference strain 
Escherichia coli ATCC 25922 was used as a negative β-lactamase control. These bacterial 
isolates have previously been described in our preceding studies[11, 13]. The characteristics 
of organisms used are presented in Table 1.   
 
 2.2 Nitro-Carba test (NCT) 
The NCT is based upon the hydrolysis of nitrocefin by carbapenemases in the presence of 
carbapenem antibiotics. The assay was prepared and performed as follows. For each bacterial 
isolate one full inoculation loop (10 µL) of tested colonies, grown overnight at 37 °C on LB 
agar was selected. To extract the enzymes, the sample was resuspended in 500 µL of lysis 
buffer containing 0.04% CTAB (Sigma-Aldrish, UK), 0.1 mM ZnSO4 (pH 7.5) and 1% 
TritonTMX-100 and vortexed vigorously for 2 min. 100 µL of extracted enzymes was added 
to wells containing either 50 µl of distilled water (control), 800 µg/mL of imipenem (IPM), 
200 µg/mL meropenem (MEM) or 80 µg/mL of ertapenem (ETP). Following incubation at 
room temperature for 5 min, 50 µL of 1 g/L nitrocefin in rehydrating fluid (OxoidTM, Thermo 
Scientific) was added into each well (the final concentrations of IPM, MEM and ETP were 
200 µg/mL, 50 µg/mL and 20 µg/mL, respectively). Upon addition of nitrocefin, a colour 
change from yellow to red in both wells containing carbapenem and wells containing water, 
was considered indicative of carbapenemase production. The absence of any colour change 
(no hydrolysis of nitrocefin) in wells containing carbapenem or wells containing water 
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indicated no carbapenemase production or no β-lactamase production, respectively. All 
results were interpreted within 20 min of incubation at room temperature. The interpreters 
were not aware of the phenotypes and molecular characteristics of organisms.   
 
2.3 Minimum inhibitory concentration (MIC) determination 
The MICs of carbapenem antibiotics including IPM, MEM and ETP (Sigma-Aldrich, UK)  
were determined using a standard broth microdilution method according to the Clinical and 
Laboratory Standards Institute (CLSI) guideline [14]. An overnight culture was harvested, 
washed and adjusted to reach 0.5 standard McFarland equivalent. Bacteria (approximately 5 x 
105 CFU/mL) were treated with a two-folded dilution series of carbapenems in Mueller-
Hinton (MH) medium. Wells in absence of antibiotics and bacteria were used as controls. 
Following incubation at 37 °C overnight, the lowest concentration showing no visible growth 
was denoted as a MIC value. The experiments were carried out in three independent 
replicates. The susceptibility profiles of carbapenems against Enterobacteriaceae isolates 
were interpreted in according to CLSI antimicrobial susceptibility breakpoint values[15]: 
IPM and MEM; susceptible ≤ 1 and resistant > 2 µg/mL and for ETP; susceptible  ≤ 0.5 and, 
resistant > 1 µg/mL.  
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3. Results and Discussion  
Human infections caused by CPEs are considerably life-threatening due to limited treatment 
options. Rapid detection of the presence of carbapenemases in Enterobacteriaceae could be 
useful for antibiotic administrations and infection control. Although several methods have 
been established, it still presents a challenge to researchers to develop new rapid and simple 
innovative methods, with high performance, that are reliable and cost-effective [16].  Hence, 
a promising approach using the NCT for rapid screening of CPE is described here in the 
present study. 
 
The NCT assay was rapidly able to detect all 31 carbapenemase producers within a quick 
timeframe of between 10 seconds and 12 min. The representative results are illustrated in 
Figure 1. All carbapenemase-producing-isolates hydrolysed nitrocefin in the antibiotic free 
control wells and wells containing carbapenem antibiotics. The sensitivities of the NCT for 
all three antibiotics were 100%. No colour changes were observed in the wells with 
antibiotics within 20 min for non-carbapenemase-producing isolates. ETP was found to 
prevent hydrolysis of nitrocefin by AmpCs and ESBLs, while IPM and MEM cannot prevent 
hydrolysis of nitrocefin by some AmpC and ESBL-producing strains. The specificities of 
IPM, MEM and ETP were 64.29% (36 out of 56), 91.07% (51 out of 56) and 100% (56 out of 
56). These findings indicated that ETP exhibits the best activity in prevention of nitrocefin 
hydrolysis by ESBL, AmpC or co-expression of ESBL and AmpC β-lactamases. In 
agreement with a previous study, discs containing ETP supplemented with nitrocefin were 
able to detect all CPE isolates within 30 min, with no false-positive and negative results [11].   
 
In comparison with Carba NP, one of the most popular methods that has been used by many 
pathology laboratories, the concentration of antibiotics used in NCT is  much lower than 
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those indicated in the  Carba NP [17] and also Blue-Carba test manuals [18]. The NCT 
developed in the current study also provides faster results in detecting carbapenemase 
production in Enterobacteriaceae. However, a larger sample size of CPE with a variety of 
resistance mechanisms should be further investigated to validate the robustness of NCT. 
Subjectivity in interpretation of results remains the shortcoming of all chromogenic methods 
[19]. 
 
The MIC results of IPM, MEM and ETP against carbapenemase- and non-carbapenemase-
producing isolates employed in this study are summarized in Table 1.  IPM, MEM and ETP 
against all carbapenemase-producing strains had MIC values ranging from 0.5 to ≥256, 0.25 
to ≥256 and 1 to ≥256 µg/mL, respectively. OXA-48-producing isolates showed lower MIC 
values compared with producers of MBL and KPC. Three OXA-48 carbapenemase producers 
found to be susceptible to IPM, while four OXA-48 carbapenemase producers were sensitive 
to MEM. OXA-48 like carbapenemase enzymes often weakly hydrolyse carbapenems 
resulting in the MIC value which may not be high enough to be designated  resistant or 
intermediately resistant [20].  This is consistent with the results from the current study which 
demonstrates that some OXA-48-producing strains are sensitive and intermediately resistant 
to carbapenems.  
 
The majority of non-carbapenemase producers were still susceptible to carbapenem 
antibiotics, with the exception of an AmpC producer (ACT-1-producing E. aerogenes) which 
was found to be resistant to IPM at a MIC of 4 µg/mL. This could be due to overexpression 
of some ACT-types that can degrade carbapenems at low rates. However, nitrocefin can 
discriminate a non-carbapenemase producer of IPM-resistant E. aerogenes with AmpC β-
lactamase production [21].  Taken together, the findings from this study suggest that the NCT 
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can effectively detect the presence of carbapenemase in carbapenem-susceptible isolates, in 
particular OXA-48 producers. The NCT can also discriminate carbapenemase-producing 
isolates from hyperproduction of ESBL or AmpC β-lactamases.   
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4. Conclusion 
A rapid and reliable method that can detect the presence of carbapenemase production in 
Enterobacteriaceae is important for controlling the spread of antibiotic resistant pathogens, 
screening patients and rational use of chemotherapy. The NCT assay we propose here is a 
very simple, reliable and cost-effective method, allowing rapid visual observation of results  
within 20 min. ETP shows the best sensitivity and specificity, and so  should be selected for 
future investigation in a clinical setting whilst other carbapenems can be excluded. This assay 
is a promising alternative method that can be applicable in any laboratory for screening CPE.    
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Figure legend 
Figure 1.  Representative results from Nitro-Carba test. CT = control (water); IPM 
=imipenem (200 µg/ml); MEM = meropenem (50 µg/ml); ETP = ertapenem (20 µg/ml). 1) 
VIM-1+SHV-12-producing K. pneumoniae 4034; 2) OXA-48-producing K. pneumoniae 
4026; 3) VIM-1+SHV-102-producing K. pneumoniae 4033; 4) OXA-48-producing K. 
pneumoniae 4012; 5) DHA-1-producing E. coli  2003; 6) CTX-M-9+ACT-18-producing E. 
coli 3003; 7) OXA-48-producing E. cloacae  4003; 8) OXA-48-producing E. coli 4010; 9) 
NDM-1-producing E. cloacae 4004; 10) KPC-3-producing E. coli 4006; 11) KPC-2-
producing K. oxytoca 4032; 12) CTX-M-3+ACT-1-producing C. freundii 3005; 13) non-β-
lactamase-producing E. coli ATCC 25922; 14)  NDM-1-producing E. coli 4011; 15) KPC-3-
producing K. pneumoniae 4014; 16) KPC-producing K. pneumoniae 4018; 17) OXA-48-
producing E. coli 4007; 18) OXA-48-producing K. pneumoniae 4021; 19) DHA-1-producing 
K. pneumoniae 2001; 20) DHA-1-producing E. coli 2002; 21) CTX-M-15+SHV-27-
producing K. pneumoniae 1010; 22) SHV-12+CTXM-9+ACT-32-producing E. aerogenes 
3002; 23) ACT-32-producing E. cloacae 2009; 24)  CTX-M-15-producing E. coli NCTC 
13353. 
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Table 1. Organism characteristics and minimum inhibitory concentrations (MICs) of carbapenemase-producing-and non-carbapenemase-
producing isolates used in this study. 
Group of β-lactamases Species 
 (no. of strains) 
MIC(s) 
(µg/mL) 
 Nitro-Carba test  
Time to detection of positive result [Minute (second)] 
IPM MEM ETP 
 control 
(H2O) 
IPM  
(200 µg/mL) 
MEM  
(50 µg/mL) 
ETP 
(20 µg/mL) 
Carbapenemase producers (n = 31)         
class A (n =9) KPC K. pneumoniae (6) 16 - ≥ 256 8 - ≥256 32 - ≥256  0(6) - 6(30) 0(10) - 7(20) 0(10) – 7(29) 0(10) - 9(45) 
  K. oxytoca (1) 4 8 16  2(1) 2(10) 5(47) 5(47) 
  E. coli  (2) 16 - 32 8 - 64 16 - 128  1(10) - 1(51) 1(51) - 12(4) 1(51) – 12(4) 1(51) - 12(4) 
class B (n=11) IMP K. ozaenae (1)   4 16 8  0(20) 0(35) 0(35) 0(35) 
 NDM E. cloacae (2) 64 - ≥256 128 - ≥256 128 - ≥256  0(20) - 3(10) 0(32) 0(47) 0(47) 
  K. pneumoniae  (3) 16 - 128 32 - ≥256 32 - ≥256  0(25) - 1(23) 1(40) - 8(0) 4(30) – 12(0) 4(32) - 12(0) 
  E. coli (1) ≥256 ≥256 ≥256  0(10) 4(11) 5(4) 5(4) 
 VIM* K. pneumoniae  (4) 8 – 64 8 - ≥256 8 -128  0(15) - 1(20) 0(17) - 1(53) 0(17) - 1(53) 0(17) - 2(4) 
class D (n=11) OXA-48 E. cloacae (2) 2 - 4  2 8 – 16  0(8) - 0(30) 2(1) - 5(17) 5(6) - 6(14) 5(10) - 6(14) 
  K. pneumoniae  (5) 1 - ≥256 1 - 64 4 - ≥256  0(5) – 0(51) 0(16) - 5(40) 2(0) - 11(32) 1(32) - 11(30)  
  E. coli (4) 0.5 - 8 0.25 - 8 1 – 32  0(8) - 1(2) 1(42) - 7(11) 3(1) - 8(28) 2(36) - 8(28) 
Non-carbapenemase producers (n = 56)         
class A (n=15) ESBL E. coli (7) ≤0.25 – 0.5 ≤0.25 ≤0.25  0(15) - 9(30) 16(30) - >20 >20 >20 
  K. pneumoniae  (7) ≤0.25 – 1 ≤0.25 ≤0.25  0(32) - 8(10)  16(30) - >20 >20 >20 
  E. cloacae (1) ≤0.25 ≤0.25 ≤0.25  0(40) 0(55) >20 >20 
class C (n=32) AmpC K. pneumoniae  (4) 0.5 – 1 ≤0.25 ≤0.25 – 1  0(7) - 2 2(23) - >20 >20 >20 
  E. coli (10) ≤0.25 – 2 ≤0.25 – 0.5 ≤0.25 – 1  0(5) - 2(2) 0(12) - >20  5(20) - >20 >20 
  C. freundii (2) 0.5 – 1 ≤0.25 ≤0.25 – 1  0(14) 4(0) - 7(0) >20 >20 
  E. aerogenes (7) 0.5 - 4  ≤0.25 ≤0.25 – 0.5  0(15) - 4(26) 4(30) - >20 >20 >20 
  E. cloacae (7) ≤0.25 – 2 ≤0.25 ≤0.25 - 1  0(5) - 4(17) 4(0) - >20 10(0) - >20 >20 
  M. morganii (2) 1 - 2 ≤0.25 ≤0.25  0(10) - 0(12) 2(39) - 9(0) 8(40) - 10(0) >20 
Class A +  
Class C (n=9) 
ESBL+ 
AmpC 
E. aerogenes (5)   ≤0.25 – 1 ≤0.25 ≤0.25  1(10) - 14(0) 10(0) - >20 >20 >20 
E. cloacae (1)   1 ≤0.25 ≤0.25  1(20) >20 >20 >20 
  C. freundii (2) 1 ≤0.25 ≤0.25  2(10) - 2(36) >20 >20 >20 
  E. coli (1) 0.5 ≤0.25 ≤0.25  1(30) >20 >20 >20 
Negative control  E. coli ATCC 25922 0.5 ≤0.25 ≤0.25  >20 >20 >20 >20 
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*One VIM-1+SHV-12 and one VIM-1+SHV-102 co-producer 
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